Search research articles
Contact Us
Filters
Showing results (51-60 of 278) with videos related to
Page
of 28
Sort By:
The Journal of Antimicrobial Chemotherapy
|
September 18, 2010
Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia
Michael A Pfaller, Rodrigo E Mendes, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2010
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates
Rodrigo E Mendes, Gary J Moet, Mike J Janechek, et al.
Journal of Global Antimicrobial Resistance
|
July 21, 2019
Regional analysis of telavancin and comparator antimicrobial activity against multidrug-resistant Staphylococcus aureus collected in the USA 2014-2016
Leonard R Duncan, Caitlin J Smith, Robert K Flamm, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 15, 2021
Tedizolid activity against a multicentre worldwide collection of Staphylococcus aureus and Streptococcus pneumoniae recovered from patients with pneumonia (2017-2019)
Cecilia G Carvalhaes, Helio S Sader, Paul R Rhomberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2008
Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates
Rodrigo E Mendes, Thomas R Fritsche, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
November 13, 2019
Meropenem-Vaborbactam Activity against Carbapenem-Resistant <i>Enterobacterales</i> Isolates Collected in U.S. Hospitals during 2016 to 2018
Mariana Castanheira, Timothy B Doyle, Valerie Kantro, et al.
Antimicrobial Agents and Chemotherapy
|
July 16, 2014
Revised reference broth microdilution method for testing telavancin: effect on MIC results and correlation with other testing methodologies
David J Farrell, Rodrigo E Mendes, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
April 18, 2012
Worldwide appraisal and update (2010) of telavancin activity tested against a collection of Gram-positive clinical pathogens from five continents
Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2017
Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016
Helio S Sader, Rodrigo E Mendes, Jennifer M Streit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2012
Oritavancin microbiologic features and activity results from the surveillance program in the United States
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Page
of 28
Search research articles
Search
Showing results (51-60 of 278) with videos related to
Sort By:
Page
of 28
The Journal of Antimicrobial Chemotherapy
|
September 18, 2010
Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia
Michael A Pfaller, Rodrigo E Mendes, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2010
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates
Rodrigo E Mendes, Gary J Moet, Mike J Janechek, et al.
Journal of Global Antimicrobial Resistance
|
July 21, 2019
Regional analysis of telavancin and comparator antimicrobial activity against multidrug-resistant Staphylococcus aureus collected in the USA 2014-2016
Leonard R Duncan, Caitlin J Smith, Robert K Flamm, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 15, 2021
Tedizolid activity against a multicentre worldwide collection of Staphylococcus aureus and Streptococcus pneumoniae recovered from patients with pneumonia (2017-2019)
Cecilia G Carvalhaes, Helio S Sader, Paul R Rhomberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2008
Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates
Rodrigo E Mendes, Thomas R Fritsche, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
November 13, 2019
Meropenem-Vaborbactam Activity against Carbapenem-Resistant <i>Enterobacterales</i> Isolates Collected in U.S. Hospitals during 2016 to 2018
Mariana Castanheira, Timothy B Doyle, Valerie Kantro, et al.
Antimicrobial Agents and Chemotherapy
|
July 16, 2014
Revised reference broth microdilution method for testing telavancin: effect on MIC results and correlation with other testing methodologies
David J Farrell, Rodrigo E Mendes, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
April 18, 2012
Worldwide appraisal and update (2010) of telavancin activity tested against a collection of Gram-positive clinical pathogens from five continents
Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2017
Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016
Helio S Sader, Rodrigo E Mendes, Jennifer M Streit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 21, 2012
Oritavancin microbiologic features and activity results from the surveillance program in the United States
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Page
of 28